The Translational Platform
From Scientific Discovery to Scalable Innovation
Transforming a scientific discovery into a real-world healthcare solution requires more than research alone.
It requires access to infrastructure, industrial expertise, multidisciplinary knowledge, intellectual property support, funding pathways and strategic partners.
WRCB-HiMedia Bioinnovation Lab
A Foundation for Bioinnovation & Translational Development
A CSR initiative by HiMedia Laboratories, the WRCB-HiMedia Bioinnovation Lab forms part of WIC’s translational infrastructure, providing a platform for advancing promising bioinnovation through research and development.
The lab represents the foundation of WIC’s growing platform ecosystem, supporting technologies as they progress toward further validation and translation.
Automation Integrated Bioassay Development Lab
Accelerating Automated Biological Testing
WIC is developing an Automation Integrated Bioassay Development Lab to strengthen its capabilities in automated biological testing and development.
The upcoming platform will form part of WIC’s broader infrastructure for enabling more efficient technology development and supporting innovations as they progress through the translational journey.
AI+PAT-Powered Bioprocess Scale-Up Facility
A Next-Generation Translational Biopharma Manufacturing Ecosystem
This facility at IIT Bombay is a next-generation, intelligent, and sustainable translational ecosystem bridging academic research and commercial manufacturing. It enables end-to-end process development, scale-up, and technology transfer across different modalities of biotherapeutics.
By integrating AI-driven predictive analytics, digital twins, and real-time monitoring, the facility optimizes yields, ensures quality, and reduces production costs. It also serves as a national resource for training and capacity building, developing a skilled workforce for next-generation biomanufacturing.
Let’s Build What Comes Next
Have a technology, research collaboration, infrastructure requirement, or investment interest?
Tell us how we can work together
↑